Announcement • Jul 07
Aimei Health Technology Co., Ltd announced that it has received $0.034331 million in funding from Aimei Health Ltd Aimei Health Technology Co., Ltd announced private placement to issue an an zero coupon unsecured promissory note in the principal amount of $34,330.96 on July 6, 2026. The transaction includes participation from returning investor Aimei Health Ltd. The Promissory Note does not bear interest and the principal thereunder becomes due and payable upon the date on which the Company consummates a business combination with United Hydrogen (the “ Business Combination ”). The Payee has the right, but not the obligation, to convert the Promissory Note, in whole or in part, into private units of the Company, at a price of $10.00 per unit, each consisting of one ordinary share and one right to receive one-fifth (1/5) of one ordinary share of the Company, immediately prior to the consummation of the Business Combination, by providing the Company with written notices of their intention to convert the Promissory Note at least two business days prior to the closing of the Business Combination. Board Change • Jul 01
Less than half of directors are independent There are 4 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (3 non-independent directors). CFO & Director Henry Wong is the most experienced director on the board, commencing their role in 2023. Independent Director Lin Bao was the last independent director to join the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of experienced directors. Announcement • Jul 01
Aimei Health Technology Co., Ltd Announces Board Changes Aimei Health Technology Co. Ltd. reported that on June 24, 2026, Ms. Julianne Huh, a director of Aimei Health Technology Co., Ltd, submitted a letter of resignation indicating her intention to resign as the Company's director, effective June 24, 2026, which has been accepted by the board of directors of the Company. Ms. Huh has advised the Company that her resignation was due to personal reasons and not a result of any disagreement with the Company on any matter related to the operations, policies, or practices of the Company. On June 29, 2026, the nominating and corporate governance committee of the Board recommended, and the Board approved and appointed Mr. Daniel Veikko Polvi to serve as a director of the Company. Mr. Polvi received his MBA degree in Business Administration from BI Norwegian Business School in June 2018. Since May 2019, Mr. Polvi has served as the managing director of Shearwater Limited, a management consulting firm providing business management consulting services to international corporations, where he is responsible for overseeing client engagements and delivering business and management consulting services to international corporate clients. The Board believes that Mr. Polvi is well qualified to serve as a director of the Company due to his extensive experience in business management, corporate advisory, and strategic consulting for international corporations. 
